| Literature DB >> 30069024 |
Xiang-Dong Zi1, Shuang Liu2, Wei Xia3, Xian-Rong Xiong2, Bin Luo2.
Abstract
During mammalian pre-implantation embryonic development, dramatic and orchestrated changes occur in gene transcription. Pregnancy rates were low when yak females were crossbred with cattle breeds, but few studies exist to describe the unique molecular network regulation behind the pre-implantation development of these embryos. We determined the transcriptomes of crossbred embryos derived from yak oocytes in vitro fertilized with Jersey sperm using Illumina RNA-seq for the first time in this study. Embryos were sampled at the 2-, 4-, and 8-cell, morula and blastocyst stages. The results showed that in total, 291.9 million short reads were generated from the five libraries of 2-, 4-, and 8-cell, morula and blastocyst stages, with 276.2 million high-quality reads selected for further analysis. Eighty to 91% of the clean reads were aligned against the yak reference genome. A total of 19,072 transcripts were identified in five libraries, of which 7,785 transcripts were co-expressed in each stage and 2,013 transcripts were stage-specific. When a |log2 ratio| ≥1 and q-value ≤ 0.05 were set as thresholds for identifying differentially expressed genes (DEGs), we detected a total of 3,690 to 10,298 DEGs between any two consecutive stages. Based on the results of GO and KEGG enrichment, some of these DEGs potentially play an important role in regulating pre-implantation development, but they are most likely stage-specific. There were 2,960, 7,287, 6,420, 7,724 and 10,417 DEGs in 2-, 4-, 8-cell, morula and blastocyst stages between the crossbred embryos and purebred embryos of the yak, respectively, leading to a large difference in GO terms and pathways. In conclusion, we sequenced transcriptomes of in vitro-produced crossbred embryos of yak and cattle during pre-implantation and provided comprehensive examinations of gene activities. These will be helpful for development of assisted reproductive technology and better understanding the early maternal-fetal or maternal-embryonic dialog in inter-species crossbreeding.Entities:
Mesh:
Year: 2018 PMID: 30069024 PMCID: PMC6070518 DOI: 10.1038/s41598-018-29912-7
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Venn diagram of gene expression during in vitro pre-implantation development of yak crossbred embryos.
Figure 2Gene transcripts with maternal or embryonic expression profiles. (A) Expression profile of maternal transcripts. (B) Expression profile of the embryonic genes.
Figure 3Number of differentially expressed genes during pre-implantation development of yak crossbred embryos. The X axis represents four different stage comparisons of pre-implantation development, including from 2-cell to 4-cell (2 v 4), from 4-cell to 8-cell (4 v 8), from 8-cell to morula (8 v M), and from morula to blastocyst (M v B).
Figure 4Overview of DEG analysis during the five consecutive stages of yak crossbred pre-implantation development. (a) Heat map of DEGs across five developmental stages, including the 2-cell (2), 4-cell (4), 8-cell (8), morula (M), and blastocyst (B) stages. (b) Expression patterns of the genes in the six main clusters, namely, K1-K6, corresponding to the heatmap. (c) GO-term function enrichment analysis of the different clusters.
Top significant GO terms of the Biological Process enriched for differentially expressed genes between subsequent stages of yak crossbred embryos.
| Stage | GO terms | GO | q-value |
|---|---|---|---|
| 2 v 4 | Detection of chemical stimulus | 0009593 | 2.29E-08 |
| Sensory perception of chemical stimulus | 0007606 | 6.63E-08 | |
| Detection of stimulus involved in sensory perception | 0050906 | 6.63E-08 | |
| Detection of chemical stimulus involved in sensory perception | 0050907 | 6.63E-08 | |
| Sensory perception | 0007600 | 2.89E-07 | |
| Detection of stimulus | 0051606 | 4.82E-07 | |
| System process | 0003008 | 1.17E-05 | |
| Biological adhesion | 0022610 | 3.48E-05 | |
| Cell adhesion | 0007155 | 3.48E-05 | |
| Homophilic cell adhesion | 0007156 | 0.0020 | |
| 4 v 8 | Detection of chemical stimulus | 0009593 | 0.0018 |
| Sensory perception of chemical stimulus | 0007606 | 0.0193 | |
| Immune system process | 0002376 | 0.0265 | |
| Detection of chemical stimulus involved in sensory perception | 0050907 | 0.0265 | |
| Inflammatory response | 0006954 | 0.0265 | |
| Defence response | 0006952 | 0.0327 | |
| Multicellular organismal process | 0032501 | 0.0327 | |
| Detection of stimulus involved in sensory perception | 0050906 | 0.0388 | |
| Detection of stimulus | 0051606 | 0.0388 | |
| Single-multicellular organism process | 0044707 | 0.0470 | |
| 8 v M | Multicellular organismal process | 0032501 | 1.11E-05 |
| Single-multicellular organism process | 0044707 | 1.11E-05 | |
| Locomotion | 0040011 | 5.85E-05 | |
| Multicellular organismal development | 0007275 | 6.19E-05 | |
| Signalling | 0023052 | 6.19E-05 | |
| Cell communication | 0007154 | 6.19E-05 | |
| Single organism signalling | 0044700 | 6.19E-05 | |
| Response to external stimulus | 0009605 | 8.05E-05 | |
| Cell surface receptor signalling pathway | 0007166 | 0.0010 | |
| System development | 0048731 | 0.0010 | |
| M v B | none |
A q-value < 0.05 was identified as significant. The number in the bracket is the count of significant GO terms.
Top significant GO terms of the Cellular Component enriched for differentially expressed genes between subsequent stages of yak crossbred embryos.
| Stage | Description | GO | q-value |
|---|---|---|---|
| 2 v 4 | Extracellular space | 0005615 | 7.00E-18 |
| Intrinsic to membrane | 0031224 | 3.80E-14 | |
| Extracellular region | 0005576 | 5.60E-14 | |
| Integral to membrane | 0016021 | 2.70E-13 | |
| Extracellular matrix | 0031012 | 3.40E-12 | |
| Intrinsic to plasma membrane | 0031226 | 4.80E-10 | |
| Proteinaceous extracellular matrix | 0005578 | 1.20E-09 | |
| Integral to plasma membrane | 0005887 | 4.10E-09 | |
| Extracellular region part | 0044421 | 7.50E-09 | |
| Membrane part | 0044425 | 3.20E-07 | |
| 4 v 8 | Plasma membrane | 0005886 | 1.00E-08 |
| Cell periphery | 0071944 | 1.20E-08 | |
| Intrinsic to plasma membrane | 0031226 | 4.70E-08 | |
| Intrinsic to membrane | 0031224 | 8.50E-08 | |
| Integral to plasma membrane | 0005887 | 9.10E-08 | |
| Integral to membrane | 0016021 | 3.00E-07 | |
| Plasma membrane part | 0044459 | 8.40E-07 | |
| Membrane part | 0044425 | 1.10E-05 | |
| Nuclear nucleosome | 0000788 | 2.30E-05 | |
| Extracellular space | 0005615 | 7.00E-05 | |
| 8 v M | Intrinsic to membrane | 0031224 | 1.60E-12 |
| Integral to membrane | 0016021 | 1.00E-11 | |
| Extracellular space | 0005615 | 1.40E-09 | |
| Plasma membrane | 0005886 | 8.40E-09 | |
| Membrane part | 0044425 | 1.20E-08 | |
| Cell periphery | 0071944 | 1.70E-08 | |
| Intrinsic to plasma membrane | 0031226 | 2.50E-08 | |
| Integral to plasma membrane | 0005887 | 5.00E-08 | |
| Plasma membrane part | 0044459 | 1.30E-07 | |
| Proteinaceous extracellular matrix | 0005578 | 0.00014 | |
| M v B | Cytosolic ribosome | 0022626 | 4.90E-06 |
| Plasma membrane | 0005886 | 1.10E-05 | |
| Cell periphery | 0071944 | 2.60E-05 | |
| Cytosolic large ribosomal subunit | 0022625 | 3.20E-05 | |
| Intrinsic to membrane | 0031224 | 3.90E-05 | |
| Extracellular space | 0005615 | 5.30E-05 | |
| Extracellular matrix | 0031012 | 8.50E-05 | |
| Integral to membrane | 0016021 | 0.00019 | |
| Integral to plasma membrane | 0005887 | 0.00028 |
A q-value < 0.05 was identified as significant. The number in the bracket is the count of significant GO terms.
Top significant GO terms of the Molecular Function enriched for differentially expressed genes between subsequent stages of yak crossbred embryos.
| Stage | Description | GO | p value |
|---|---|---|---|
| 2 v 4 | Receptor activity | 0004872 | 1.00E-13 |
| Signalling receptor activity | 0038023 | 1.10E-13 | |
| G-protein coupled receptor activity | 0004930 | 1.70E-13 | |
| Transmembrane signalling receptor activity | 0004888 | 6.80E-13 | |
| Olfactory receptor activity | 0004984 | 2.50E-12 | |
| Molecular transducer activity | 0060089 | 1.80E-11 | |
| Signal transducer activity | 0004871 | 1.80E-11 | |
| Calcium ion binding | 0005509 | 2.90E-07 | |
| Peptidase inhibitor activity | 0030414 | 6.70E-07 | |
| Potassium channel activity | 0005267 | 7.10E-07 | |
| 4 v 8 | G-protein coupled receptor activity | 0004930 | 6.00E-14 |
| Signalling receptor activity | 0038023 | 2.10E-11 | |
| Transmembrane signalling receptor activity | 0004888 | 4.60E-11 | |
| Receptor activity | 0004872 | 8.60E-11 | |
| Signal transducer activity | 0004871 | 5.50E-10 | |
| Molecular transducer activity | 0060089 | 5.50E-10 | |
| Olfactory receptor activity | 0004984 | 6.10E-06 | |
| 8 v M | Receptor activity | 0004872 | 5.30E-14 |
| Signalling receptor activity | 0038023 | 6.20E-13 | |
| Transmembrane signalling receptor activity | 0004888 | 4.70E-11 | |
| Molecular transducer activity | 0060089 | 4.00E-10 | |
| Signal transducer activity | 0004871 | 4.00E-10 | |
| G-protein coupled receptor activity | 0004930 | 4.90E-10 | |
| Calcium ion binding | 0005509 | 5.50E-05 | |
| M v B | Signalling receptor activity | 0038023 | 1.20E-05 |
A q-value < 0.05 was identified as significant. The number in the bracket is the count of significant GO terms.
Pathways enriched for differentially expressed genes between subsequent stages of yak crossbred embryos.
| Stage | Pathways | Map | q-value |
|---|---|---|---|
| 2 v 4 | Olfactory transduction | 04740 | 1.74E-09 |
| Ubiquitin-mediated proteolysis | 04120 | 0.0005 | |
| Protein processing in the endoplasmic reticulum | 04141 | 0.0081 | |
| Carbon fixation in photosynthetic organisms | 00710 | 0.0087 | |
| Cell cycle | 04110 | 0.0152 | |
| Spliceosome | 03040 | 0.0176 | |
| RNA transport | 03013 | 0.0236 | |
| Progesterone-mediated oocyte maturation | 04914 | 0.0236 | |
| Epstein-Barr virus infection | 05169 | 0.0236 | |
| Viral carcinogenesis | 05203 | 0.0236 | |
| Cytokine-cytokine receptor interaction | 04060 | 0.0258 | |
| Chronic myeloid leukaemia | 05220 | 0.0258 | |
| Glycolysis / Gluconeogenesis | 00010 | 0.0306 | |
| Microbial metabolism in diverse environments | 01120 | 0.0323 | |
| Pyruvate metabolism | 00620 | 0.0415 | |
| Cytokine-cytokine receptor interaction | 04060 | 0.0258 | |
| Chronic myeloid leukemia | 05220 | 0.0258 | |
| Glycolysis / Gluconeogenesis | 00010 | 0.0306 | |
| Microbial metabolism in diverse environments | 01120 | 0.0323 | |
| Pyruvate metabolism | 00620 | 0.0415 | |
| 4 v 8 | none | ||
| 8 v M | Ribosome | 03010 | 1.63E-13 |
| Parkinson’s disease | 05012 | 1.82E-06 | |
| Oxidative phosphorylation | 00190 | 1.88E-06 | |
| Huntington’s disease | 05016 | 1.52E-05 | |
| RNA transport | 03013 | 8.03E-05 | |
| Neuroactive ligand-receptor interaction | 04080 | 0.0025 | |
| Alzheimer’s disease | 05010 | 0.0034 | |
| Transcriptional misregulation in cancer | 05202 | 0.0036 | |
| Cardiac muscle contraction | 04260 | 0.0043 | |
| Proteasome | 03050 | 0.0062 | |
| Ribosome biogenesis in eukaryotes | 03008 | 0.0066 | |
| Ubiquitin mediated proteolysis | 04120 | 0.0185 | |
| Basal cell carcinoma | 05217 | 0.0185 | |
| ABC transporters | 02010 | 0.0185 | |
| Systemic lupus erythematosus | 05322 | 0.0195 | |
| Amoebiasis | 05146 | 0.0202 | |
| ECM-receptor interaction | 04512 | 0.0294 | |
| Steroid hormone biosynthesis | 00140 | 0.0406 | |
| Ribosome biogenesis in eukaryotes | 03008 | 0.0066 | |
| Ubiquitin mediated proteolysis | 04120 | 0.0185 | |
| Basal cell carcinoma | 05217 | 0.0185 | |
| ABC transporters | 02010 | 0.0185 | |
| Systemic lupus erythematosus | 05322 | 0.0195 | |
| Amoebiasis | 05146 | 0.0202 | |
| ECM-receptor interaction | 04512 | 0.0294 | |
| Steroid hormone biosynthesis | 00140 | 0.0406 | |
| M v B | RNA transport | 03013 | 0.0387 |
A q-value < 0.05 was identified as significant.
Figure 5The validation of results of Smart-seq2 by qRT-PCR. The X axis represents the stages of pre-implantation development, including the 2-cell (2), 4-cell (4), 8-cell (8), morula (M), and blastocyst (B) stages.
Figure 6Number of DEGs (a) and significantly enriched GO terms (b) between crossbred embryos and purebred embryos at the particular stage. BP, CC and MF indicated Biological Process, Cellular Component and Molecular Function, respectively.
Pathways enriched for differentially expressed genes between crossbred embryos and yak embryos. A q-value < 0.05 was identified as significant.
| Stage | Pathways | Map | q-value |
|---|---|---|---|
| 2-cell | RNA transport | 3013 | 2.42E-05 |
| Spliceosome | 3040 | 0.0030 | |
| Cell cycle | 4110 | 0.0060 | |
| Cell cycle - yeast | 4111 | 0.0072 | |
| Systemic lupus erythematosus | 5322 | 0.0082 | |
| Ubiquitin mediated proteolysis | 4120 | 0.0109 | |
| 4-cell | Spliceosome | 3040 | 4.34E-07 |
| Neuroactive ligand-receptor interaction | 4080 | 1.01E-05 | |
| Protein processing in endoplasmic reticulum | 4141 | 0.0010 | |
| Cytokine-cytokine receptor interaction | 4060 | 0.0015 | |
| RNA transport | 3013 | 0.0070 | |
| Ribosome biogenesis in eukaryotes | 3008 | 0.0166 | |
| RNA degradation | 3018 | 0.0224 | |
| Olfactory transduction | 4740 | 0.0394 | |
| 8-cell | Olfactory transduction | 4740 | 8.80E-15 |
| Neuroactive ligand-receptor interaction | 4080 | 1.35E-08 | |
| Ubiquitin mediated proteolysis | 4120 | 0.0000 | |
| Cell cycle - yeast | 4111 | 0.0028 | |
| Fatty acid elongation | 62 | 0.0131 | |
| Oocyte meiosis | 4114 | 0.0131 | |
| Cytokine-cytokine receptor interaction | 4060 | 0.0131 | |
| Complement and coagulation cascades | 4610 | 0.0183 | |
| Systemic lupus erythematosus | 5322 | 0.0183 | |
| Cell cycle | 4110 | 0.0242 | |
| Nucleotide excision repair | 3420 | 0.0279 | |
| RNA transport | 3013 | 0.0497 | |
| Morula | RNA transport | 3013 | 6.89E-06 |
| Ribosome biogenesis in eukaryotes | 3008 | 0.0114 | |
| Ubiquitin mediated proteolysis | 4120 | 0.0385 | |
| Blastocyst | Ribosome biogenesis in eukaryotes | 3008 | 0.0000 |
| Spliceosome | 3040 | 0.0010 | |
| RNA polymerase | 3020 | 0.0326 | |
| RNA transport | 3013 | 0.0326 |
The number in the bracket is the count of significant pathways.